Latham, Cooley Steer CG Oncology's Upsized $380M IPO
By Tom Zanki · January 24, 2024, 9:47 PM EST
Bladder-cancer therapy company CG Oncology is set to begin trading on Thursday after pricing an upsized $380 million initial public offering, represented by Latham & Watkins LLP and underwriters counsel Cooley...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login